Formulation for controlled release of drugs by combining...

Details Formulation for controlled release of drugs by combining... Formulation for controlled release of drugs by combining...

2006-05-23

2006-05-23

Webman, Edward J. (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Matrices

C424S488000, C424S499000, C424S501000, C424S426000, C424S443000

Reexamination Certificate

active

07048946

ABSTRACT:
Combinations of hydrophilic and hydrophobic entities in a biodegradable sustained release implant are shown to modulate each other's rate of release. Formulations of a therapeutically active agent and modulator provide controlled, sustained release for an extended period of time.

REFERENCES:
patent: 4304765 (1981-12-01), Shell et al.
patent: 4478818 (1984-10-01), Shell et al.
patent: 4756911 (1988-07-01), Drost et al.
patent: 4853224 (1989-08-01), Wong
patent: 4997652 (1991-03-01), Wong
patent: 5019400 (1991-05-01), Gombotz
patent: 5075115 (1991-12-01), Brine
patent: 5164188 (1992-11-01), Wong
patent: 5169638 (1992-12-01), Dennis et al.
patent: 5356629 (1994-10-01), Sander et al.
patent: 5378475 (1995-01-01), Smith et al.
patent: 5385887 (1995-01-01), Yim et al.
patent: 5443505 (1995-08-01), Wong et al.
patent: 5597897 (1997-01-01), Ron et al.
patent: 5656297 (1997-08-01), Bernstein et al.
patent: 1333770 (1988-10-01), None
patent: 0 102 265 (1984-03-01), None
patent: 0 311 065 (1988-10-01), None
patent: 0 311 065 (1989-04-01), None
patent: 0 474 098 (1992-03-01), None
patent: 95/13765 (1995-05-01), None
patent: WO 95/13765 (1995-05-01), None
R. Baker, “Controlled Release of Biologically Active Agents,”A Wiley-Interscience Publication, p. 73 (1987).
G. DiColo, “Controlled drug release from implantable matrices based on hydrophobic polymers,”Biomaterials 1992, vol. 13, No. 12:850-853.
T. Jackanicz et al, “Polylactic Acid As A Biodegradable Carrier For Contraceptive Steroids,”Contraception, vol. 8, No. 3: 227-235.
R. Miller et al, “Degradation Rates of Oral Resorbable Implants (Polylactates and Polyglycolates): Rate Modification with Changes in PLA/PGA Copolymer Ratios,”J. Biomed. Mater. Res.,vol. 11:711-719 (1977).
J. Heller, “Biodegradable Polymers in Controlled Drug Delivery,”CRC Critical Reviews in Therapeutic Drug Carrier Systems, vol. 1, Issue 1:39-90.
Heller, J. “Bioerodible Hydrogels”,Hydrogels in medicine and pharmacy, vol. III properties and applications, N.A. Peppas, Ed., Chp. 7, pp. 137-149. CRC Press, Boca Raton, Florida (1987).
The United States Pharmacopeia, The National Formulary;USP23/NF 18; 1995; pp. 1790-1798.
Hockel M. et al.,Prevention of Peritoneal Adhesions in the Rat With Sustained Intraperitoneal Dexamethasone Delivered by a Novel Therapeutic System, Annales Chirurgiae et Gynaecologiae, vol. 76, No. 6, 1987, pp. 306-313.
Cheng, Cheng-Kuo et al.,Intravitreal Sustained-Release Dexamethasone Device in the Treatment of Experimental Uveitis, Investigative Ophthalmology & Visual Science, Feb. 1995, vol. 36, No. 2, pp. 442-453.
Enyedi, Laura et al.,An Intravitreal Device Providing Sustained Release of Cyclosporine and Dexamethasone, Current Eye Research (1995) pp. 549-557.
Hainsworth, Dean P. et al.,Sustained Release Intravitreal Dexamethasone, Journal of Ocular Pharmacology and Therapeutics, (1996) vol. 12, No. 1, pp. 57-63.
Kochinke, F. et al.,Biodegradable Drug Delivery System for Uveitis Treatment, Investigative Ophthalmology & Visual Science, Feb. 15, 1996, vol. 37. No. 3, 186-B98.
Morita Y., et al.,Intravitreous delivery of dexamethasone sodium m-sulfobenzoate from poly(DL-lactic acid)implants, Biol. Pharm. Bull., Feb. 1998; 21(2): 188-90.
Nakamura O., et al.,Inhibition of neovascularization and tumor growth by dexamethasone, No To Shinkei, Jan. 1992;44(1):37-41.
Dohlman C. et al.,Treatment of corneal edema with a buried implant, Tr. Am. Acad. Opth. & Otol., Mar.-Apr. 1966, pp. 267-280.

Affiliated with

Also associated with

Rating

Formulation for controlled release of drugs by combining... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulation for controlled release of drugs by combining..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation for controlled release of drugs by combining... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3574630